Investigation of long non-coding RNAs in extracellular vesicles from low-volume blood serum specimens of colorectal cancer patients

Logo poskytovatele
Logo poskytovatele

Varování

Publikace nespadá pod Fakultu sportovních studií, ale pod Lékařskou fakultu. Oficiální stránka publikace je na webu muni.cz.
Autoři

BOUDNÁ Marie MACHÁČKOVÁ Táňa VYCHYTILOVÁ Petra TRACHTOVÁ Karolína BARTOŠOVÁ Renata CATELA IVKOVIĆ Tina AL TUKMACHI Dagmar JUGAS Robin PIFKOVÁ Lucie ORLÍČKOVÁ Jana KOTOUČEK Jan PAVLIKOVA Marketa ŠACHLOVÁ Milana BOHOVICOVÁ Lucia STANĚK Teodor HALÁMKOVÁ Jana KISS Igor GROLICH Tomáš SVOBODA Martin KALA Zdeněk SOUČKOVÁ Kamila SLABÝ Ondřej

Rok publikování 2024
Druh Článek v odborném periodiku
Časopis / Zdroj CLINICAL AND EXPERIMENTAL MEDICINE
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
www https://link.springer.com/article/10.1007/s10238-024-01323-1
Doi http://dx.doi.org/10.1007/s10238-024-01323-1
Klíčová slova Biomarker; Colorectal cancer; EVs; lncRNAs.
Přiložené soubory
Popis Colorectal cancer (CRC) is the second most prevalent cancer type worldwide, which highlights the urgent need for non-invasive biomarkers for its early detection and improved prognosis. We aimed to investigate the patterns of long non-coding RNAs (lncRNAs) in small extracellular vesicles (sEVs) collected from low-volume blood serum specimens of CRC patients, focusing on their potential as diagnostic biomarkers. Our research comprised two phases: an initial exploratory phase involving RNA sequencing of sEVs from 76 CRC patients and 29 healthy controls, and a subsequent validation phase with a larger cohort of 159 CRC patients and 138 healthy controls. Techniques such as dynamic light scattering, transmission electron microscopy, and Western blotting were utilized for sEV characterization. Optimized protocol for sEV purification, RNA isolation and preamplification was applied to successfully sequence the RNA content of sEVs and validate the results by RT-qPCR. We successfully isolated sEVs from blood serum and prepared sequencing libraries from a low amount of RNA. High-throughput sequencing identified differential levels of 460 transcripts between CRC patients and healthy controls, including mRNAs, lncRNAs, and pseudogenes, with approximately 20% being lncRNAs, highlighting several tumor-specific lncRNAs that have not been associated with CRC development and progression. The validation phase confirmed the upregulation of three lncRNAs (NALT1, AL096828, and LINC01637) in blood serum of CRC patients. This study not only identified lncRNA profiles in a population of sEVs from low-volume blood serum specimens of CRC patients but also highlights the value of innovative techniques in biomolecular research, particularly for the detection and analysis of low-abundance biomolecules in clinical samples. The identification of specific lncRNAs associated with CRC provides a foundation for future research into their functional roles in cancer development and potential clinical applications.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info